XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
    Assets measured at fair values on a recurring basis
    We measure and report our cash equivalents, restricted cash, marketable equity securities and available-for-sale debt securities at fair value on a recurring basis. The following tables summarize the fair value of these financial assets by significant investment category and their levels within the fair value hierarchy (in thousands):
June 30, 2023December 31, 2022
Level ILevel IILevel IIITotal Level ILevel IILevel IIITotal
Financial Assets:
Cash Equivalents:
Money market funds $574,779 $— $— $574,779 $322,294 $— $— $322,294 
Commercial paper— — — — — 5,422 — 5,422 
U.S. government notes99,898 — — 99,898 51,986 — — 51,986 
Agency securities— 14,986 — 14,986 — 17,559 — 17,559 
674,677 14,986 — 689,663 374,280 22,981 — 397,261 
Marketable Securities:
Commercial paper— 88,960 — 88,960 — — — — 
Certificates of deposits(1)
— 6,998 — 6,998 — 10,492 — 10,492 
U.S. government notes783,513 — — 783,513 993,955 — — 993,955 
Corporate bonds— 1,051,495 — 1,051,495 — 1,113,134 — 1,113,134 
Agency securities— 523,491 — 523,491 — 215,380 — 215,380 
Marketable equity securities(2)
24,833 — — 24,833 19,061 — — 19,061 
808,346 1,670,944 — 2,479,290 1,013,016 1,339,006 — 2,352,022 
Other Assets:
Money market funds - restricted856 — — 856 4,271 — — 4,271 
Total Financial Assets$1,483,879 $1,685,930 $— $3,169,809 $1,391,567 $1,361,987 $— $2,753,554 
______________________________________
(1) As of June 30, 2023 and December 31, 2022, all of our certificates of deposits were domestic deposits.
(2) The $24.8 million represents the fair value of marketable equity securities as of June 30, 2023. This publicly-traded equity investment generated an unrealized gain of $5.8 million for the six months ended June 30, 2023, and an unrealized gain of $11.3 million for the three months ended June 30, 2023. Total initial cost for this investment was $3.0 million with no changes since our initial investment. The unrealized gains and losses are included in Other income (expense), net on the unaudited Condensed Consolidated Statements of Operations. Refer to Note 3. Financial Statements Details.
    During the three and six months ended June 30, 2023, the Company did not make any transfers between the levels of the fair value hierarchy.
    Marketable debt securities
    The following table summarizes the amortized cost, unrealized gains and losses, and fair value of our debt securities measured at fair value on a recurring basis (in thousands):
June 30, 2023December 31, 2022
Amortized CostUnrealized GainsUnrealized LossesFair ValueAmortized CostUnrealized GainsUnrealized LossesFair Value
Commercial paper$88,960 $— $— $88,960 $— $— $— $— 
U.S. government790,970 34 (7,491)783,513 1,007,175 (13,223)993,955 
Corporate bonds1,059,915 111 (8,531)1,051,495 1,125,920 271 (13,057)1,113,134 
Agency securities527,766 (4,283)523,491 217,893 83 (2,596)215,380 
Total $2,467,611 $153 $(20,305)$2,447,459 $2,350,988 $357 $(28,876)$2,322,469 
    For debt securities in unrealized loss positions, it is not likely that we will be required to sell such securities before recovery of their amortized cost basis nor do we have the intent to sell such securities before maturity. We invest in debt securities that have maximum maturities of two years and are generally deemed to be low risk based on their credit ratings from the major rating agencies. The longer the duration of these marketable securities, the more susceptible they are to changes in market interest rates and bond yields. Given the short-term and conservative nature of our portfolio, our debt securities are generally not subject to credit risk; therefore, we did not recognize any credit losses or non-credit-related impairments related to such securities for the three and six months ended June 30, 2023. All unrealized losses were recognized in other comprehensive income (loss). Realized losses were immaterial for the three and six months ended June 30, 2023.
    The following table is an analysis of our marketable debt securities in unrealized loss positions (in thousands):
June 30, 2023
Unrealized Losses within 12 months Unrealized Losses 12 months or greaterTotal
Fair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized Losses
U.S. government notes$457,325 $(3,346)$291,908 $(4,145)$749,233 $(7,491)
Corporate bonds743,043 (4,714)256,414 (3,817)999,457 (8,531)
Agency securities432,179 (3,063)61,730 (1,220)493,909 (4,283)
Total $1,632,547 $(11,123)$610,052 $(9,182)$2,242,599 $(20,305)
     As of June 30, 2023, we had no marketable debt securities with contractual maturities that exceed 24 months. The fair values of marketable debt securities, by remaining contractual maturities, are as follows (in thousands):
June 30, 2023
Fair Value
Due in 1 year or less$1,494,804 
Due in 1 to 2 years952,655 
Total debt securities $2,447,459 
    The weighted-average remaining duration of our marketable debt securities is approximately 0.9 years as of June 30, 2023. As we view these marketable debt securities as available to support current operations, we classify marketable debt securities with maturities beyond 12 months as current assets under the caption "Marketable securities" on the condensed consolidated balance sheets.
Assets measured at fair value on a non-recurring basis
    Non-Marketable Equity Securities
    We have non-marketable equity securities in privately-held companies that do not have readily-determinable fair values. These equity securities are included in Investments on the condensed consolidated balance sheets. Their initial cost is adjusted to fair value on a non-recurring basis based on observable price changes from orderly transactions of identical or similar securities of the same issuer, or for impairment. These investments are classified within Level III of the fair value hierarchy as we estimate the value based on valuation methods using the observable transaction price at the transaction date and other significant unobservable inputs, such as volatility, rights, and obligations related to these securities. In addition, the valuation requires management judgment due to the absence of market price and lack of liquidity.
We did not record any realized gains for our non-marketable equity securities during the three and six months ended June 30, 2023 and June 30, 2022, and we recorded an immaterial amount of realized and unrealized losses for the three and six months ended June 30, 2023 and June 30, 2022. Unrealized gains for our non-marketable equity securities are summarized below (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Unrealized gains on non-marketable equity securities (1)
$13,401 $— $13,401 $15,000 
(1) These unrealized gains were recorded on investments that were re-measured to fair value as of the date observable transactions occurred.
We evaluate our non-marketable equity securities for impairment at each reporting period via a qualitative assessment with various potential impairment indicators, including, but not limited to, an assessment of a significant adverse change in the economic environment, significant adverse changes in the general market condition of the geographies and industries in which our investees operate, and other publicly-available information that affected the value of the non-marketable equity securities.
    The following table summarizes the activity related to our non-marketable equity securities as of June 30, 2023 and December 31, 2022 (in thousands):
June 30, 2023December 31, 2022
Cost of investments(1)
$31,656 $23,625 
Cumulative impairment and downward adjustment— (888)
Cumulative upward adjustment 30,132 16,731 
Carrying amount of investments$61,788 $39,468 
(1) During the three months ended June 30, 2023, we had an $8.0 million convertible note previously included in other assets, plus accrued interest of $0.6 million, that was converted to an equity investment and included in cost of investments.